Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients

Figure 6

Risk factor-adjusted outcomes: efficacy, AE, HRQoL, and cost.

(a)

(b)

(c)

(d)